PREV Share Price Performance
CA$0.035
0.02 (133.33%)
Price CA$0.035
Share PriceCA$0.035
PreveCeutical Medical Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
PREV Community Narratives
There are no narratives available yet.
Recent PREV News & Updates
PreveCeutical Medical Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.0044
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- -63.6%
PreveCeutical Medical Inc. Competitors
Snowflake Analysis
About PREV
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; and BSV Peptide Program that targets cancer progression. The company is headquartered in West Vancouver, Canada.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Canadian Market Performance
- 7 Days: 1.1%
- 3 Months: 10.3%
- 1 Year: 22.1%
- Year to Date: 20.3%
The market is up 1.1% over the last week, with the Materials sector leading the way, up 2.7%. The market is up 22% over the last 12 months. Looking forward, earnings are forecast to grow by 11% annually. Market details ›